Trevena
TRVN
#10610
Rank
โ‚น0.86 M
Marketcap
โ‚น1.00
Share price
0.00%
Change (1 day)
-99.31%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -โ‚น2.59 Billion

According to Trevena's latest financial reports the company's current earnings are โ‚น0.54 Million. In 2023 the company made an earning of -โ‚น3.3 Billion, an increase over its 2022 earnings that were of -โ‚น4.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น2.59 Billion-21.39%
2023 -โ‚น3.3 Billion-30.69%
2022 -โ‚น4.76 Billion1.38%
2021 -โ‚น4.69 Billion78.04%
2020 -โ‚น2.64 Billion21.3%
2019 -โ‚น2.18 Billion-13.91%
2018 -โ‚น2.53 Billion-59.75%
2017 -โ‚น6.27 Billion-31.77%
2016 -โ‚น9.19 Billion101.73%
2015 -โ‚น4.56 Billion1.14%
2014 -โ‚น4.51 Billion114.83%
2013 -โ‚น2.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น747.57 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.093 T-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚น7.2 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น68.19 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚น0.94 Billion-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚น5.7 Billion 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚น56.86 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA